Nprl3 is required for normal development of the cardiovascular system

Area of Science:

• Genetics and Molecular Biology
• Developmental Biology
• Cardiovascular Research

Background:

• NPRL3 (C16orf35) is a conserved gene, orthologous to yeast Npr3, and part of a complex regulating cell metabolism via the TOR pathway.
• The NPRL3 gene is located adjacent to the human α-globin cluster and is widely expressed across vertebrate species.

Purpose of the Study:

• To investigate the function of NPRL3 in mammalian development by analyzing a knockout mouse model.
• To determine the impact of NPRL3 deficiency on gene expression and embryonic development, particularly cardiovascular formation.

Main Methods:

• Homologous recombination was used to create a mouse model with abolished NPRL3 expression.
• RNA expression analysis was performed to identify affected genes and pathways.
• Phenotypic analysis of homozygous mutant embryos was conducted to identify developmental abnormalities.

Main Results:

• Abolition of NPRL3 expression primarily affected genes regulating protein synthesis and cell cycle, suggesting mTOR pathway perturbation.
• Homozygous NPRL3 mutant embryos exhibited significant cardiovascular defects, including outflow tract abnormalities and ventriculoseptal defects.
• Embryonic lethality occurred late in gestation, indicating NPRL3's critical role in late-stage development.

Conclusions:

• Perturbation of the mTOR pathway due to NPRL3 deficiency significantly impacts embryonic cardiovascular development.
• NPRL3 is a critical gene for heart development, and mutations may contribute to congenital cardiovascular abnormalities.
• This study identifies NPRL3 as a candidate gene for human cardiovascular developmental disorders.